Abstract:Background: Chronic kidney disease (CKD) is associated with cardiac hypertrophy that leads to increased cardiovascular morbidity and mortality. To date, use of the renin-angiotensin-aldosterone system blockade has been the main treatment modality. However, renin-angiotensin-aldosterone system blockade by the angiotensin converting enzyme inhibitors (ACEi) can only partially reverse the cardiac hypertrophy without having a significant impact on all-cause mortality as evidenced by meta-analyses from clinical trials. It is imperative to elucidate the molecular pathogenesis of CKD-related cardiomyopathy for potential targets in further treatment. Methods: Male Sprague-Dawley rats that underwent subtotal nephrectomy (SNX) rats were established as the CKD model. A hemodynamic study was used to evaluate the left ventricle (LV) structural and functional alterations. We used proteomic techniques to profile the LV protein changes among sham-operated rats, SNX rats, and SNX rats with 6 months of ACEi enalapril interventions. The differentially expressed proteins were further annotated by functional and network analyses. Results: As compared to the sham-operated rats, the SNX rats had 25 upregulated and 46 decreased protein expression. The top canonical pathways identified by ingenuity pathway analysis for the CKD cardiomyopathy were mitochondrial dysfunction, oxidative phosphorylation, fatty acid β oxidation, protein ubiquitination, and ketolysis. The most relevant functions extracted from these networks contained 27 and 23 focused proteins, respectively. They were related to cellular assembly and organization, RNA posttranscriptional modification, and protein synthesis. After ACEi intervention for 6 weeks, the residual canonical pathways identified by ingenuity pathway analysis that mediated the CKD-related cardiomyopathy were mitochondrial dysfunction, ketolysis, phenylalanine degradation IV, and putrescine degradation III. There were decreased Sirt3 and SNRNP, and increased monoamine oxidase and SAHH expression in the LV of SNX rats that could not be reversed by the ACEi. Conclusion: Our studies provide a repertoire of potential biomarkers related to cardiac hypertrophy in CKD. There are still residual disturbed molecules/pathways despite ACEi intervention. Further studies are warranted to investigate these potential novel targets to alleviate CKD-related cardiomyopathy.

Comparative analysis of the proteome of left ventricular heart of arteriosclerosis in rat.

Differential Proteomics Analysis of Left Ventricular Hypertrophy in Hypertensive Rats with Abdominal Aortic Constriction

The Analysis of Ultrastructure and Gene Expression of Sarco/endoplasmic Reticulum Calcium Handling Proteins in Alloxan-Induced Diabetic Rat Myocardium.

Alteration of mevalonate pathway related enzyme expressions in pressure overload-induced cardiac hypertrophy and associated heart failure with preserved ejection fraction.

Comparative proteomic analysis of rat left ventricle in a subtotal nephrectomy model

Proteomics analysis in myocardium of spontaneously hypertensive rats

Compared Proteomic Study of Rat Model of Acute Myocardial Infarction

Alterations of myocardial ultrastructure and gene expression of calcium handling proteins in diabetic rat heart]

Proteomic Analysis Of Rat Myocardial Infarction Model

Proteome Analysis of the Left Ventricle in the Vitamin D₃ and Nicotine-Induced Rat Vascular Calcification Model.

A Proteomic Approach to Determine Changes in Proteins Involved in the Myocardial Metabolism in Left Ventricles of Spontaneously Hypertensive Rats

Metabolic and Proteomic Profiling of Coronary Microvascular Dysfunction: Insights from Rat Models

Illuminating the Molecular Basis of Diabetic Arteriopathy: A Proteomic Comparison of Aortic Tissue from Diabetic and Healthy Rats

Comparative proteomic analysis of rat aorta in a subtotal nephrectomy model

Proteomic and Phosphoproteomic Analysis of Right Ventricular Hypertrophy in the Pulmonary Hypertension Rat Model

Cardiac Proteome Profiling in Ischemic and Dilated Cardiomyopathy Mouse Models.

Analysis of differentially expressed genes related to the development of diabetic cardiomyopathy in the myocardium of type-2 diabetic rats

[Comparison of Changes in Left Ventricular Gene Expression Profiles from Different Cardiac Hypertrophy Models in Rats].

In-depth proteomic profiling of left ventricular tissues in human end-stage dilated cardiomyopathy

Differential metal content and gene expression in rat left ventricular hypertrophy due to hypertension and hyperactivity

Pathological mechanism of heart failure with preserved ejection fraction in rats based on iTRAQ technology